| Year | County | Venture Firm | Company | Stage | Amount ($K) |
| 2000 | Montgomery | CEO Venture Fund | Cell Pathways, Inc. | Balanced Stage | $100.00 |
| 2000 | Montgomery | Oxford Bioscience Partners | InKine Pharmaceutical Company, Inc. | Balanced Stage | $129.00 |
| 2000 | Chester | Flagship Ventures | Adolor Corporation | Early Stage | $200.00 |
| 2000 | Mercer | Oxford Bioscience Partners | Coelacanth Chemical Corp. | Balanced Stage | $219.00 |
| 2000 | Chester | Anthem Capital Management | Message Pharmaceuticals, Inc. | Early Stage | $262.00 |
| 2000 | Chester | TL Ventures (FKA: Radnor Venture Partners) | Adolor Corporation | Balanced Stage | $350.00 |
| 2000 | Chester | SightLine Partners | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Balanced Stage | $500.00 |
| 2000 | Chester | Individuals | Morphotek, Inc. | Balanced Stage | $666.70 |
| 2000 | Mercer | Undisclosed Venture Firm | Coelacanth Chemical Corp. | Balanced Stage | $780.00 |
| 2000 | Chester | S.R. One, Limited | Adolor Corporation | Later Stage | $850.00 |
| 2000 | Chester | Undisclosed Venture Firm | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Balanced Stage | $882.40 |
| 2000 | Chester | Opus Capital | Adolor Corporation | Later Stage | $920.00 |
| 2000 | Chester | Undisclosed Venture Firm | Adolor Corporation | Balanced Stage | $920.00 |
| 2000 | Chester | Perennial Ventures (FKA: Tredegar Investments) | Adolor Corporation | Early Stage | $1,000.00 |
| 2000 | Chester | Scale Venture Partners (FKA: BA Venture Partners) | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Balanced Stage | $1,200.00 |
| 2000 | Chester | Undisclosed Investor | Morphotek, Inc. | Balanced Stage | $1,333.40 |
| 2000 | Chester | S.R. One, Limited | Message Pharmaceuticals, Inc. | Later Stage | $1,520.00 |
| 2000 | Chester | New Enterprise Associates | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Early Stage | $1,750.00 |
| 2000 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Immunicon Corporation | Balanced Stage | $2,000.00 |
| 2000 | Mercer | Apple Tree Partners | Coelacanth Chemical Corp. | Balanced Stage | $2,060.00 |
| 2000 | Chester | Crescendo Venture Management LLC | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Early Stage | $2,173.00 |
| 2000 | Mercer | MPM Capital (FKA: MPM Asset Management LLC) | Coelacanth Chemical Corp. | Balanced Stage | $2,191.00 |
| 2000 | Montgomery | Anthem Capital Management | Immunicon Corporation | Balanced Stage | $2,500.00 |
| 2000 | Montgomery | Undisclosed Corporate Investor | Immunicon Corporation | Balanced Stage | $2,500.00 |
| 2000 | Montgomery | Johnston Associates, Inc. | Immunicon Corporation | Balanced Stage | $2,500.00 |
| 2000 | Montgomery | Foundation Medical Partners | Immunicon Corporation | Balanced Stage | $2,500.00 |
| 2000 | Montgomery | Johnson & Johnson Development Corporation | Immunicon Corporation | Later Stage | $2,500.00 |
| 2000 | Montgomery | MDS Health Ventures, Inc. (AKA: MDS Capital Corp.) | Immunicon Corporation | Expansion | $2,500.00 |
| 2000 | Montgomery | Undisclosed Venture Firm | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Balanced Stage | $2,500.00 |
| 2000 | Montgomery | Delphi Ventures | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $3,000.00 |
| 2000 | Chester | Alta Partners | Adolor Corporation | Early Stage | $3,620.00 |
| 2000 | Chester | ARCH Venture Partners | Adolor Corporation | Seed Stage | $3,670.00 |
| 2000 | Chester | Alliance Technology Ventures | Neuronyx, Inc. | Seed Stage | $3,940.00 |
| 2000 | Montgomery | Undisclosed Venture Firm | Octagen Corporation | Balanced Stage | $4,500.00 |
| 2000 | Chester | Lombard Odier Darier Hentsch (FKA: Lombard Odier & Cie) | Adolor Corporation | Early Stage | $4,641.40 |
| 2000 | Chester | OrbiMed Advisors LLC | Adolor Corporation | Later Stage | $4,641.40 |
| 2000 | Chester | Zesiger Capital Group, LLC | Adolor Corporation | Balanced Stage | $4,641.40 |
| 2000 | Chester | MPM Capital (FKA: MPM Asset Management LLC) | Adolor Corporation | Balanced Stage | $6,000.00 |
| 2000 | Chester | Opus Capital | Adolor Corporation | Expansion | $6,061.40 |
| 2000 | Montgomery | Prism Venture Partners | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $6,500.00 |
| 2000 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Neuronyx, Inc. | Early Stage | $6,660.00 |
| 2000 | Montgomery | Origin Ventures, LLC | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Seed Stage | $8,937.50 |
| 2000 | Montgomery | Perennial Ventures (FKA: Tredegar Investments) | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $8,937.50 |
| 2000 | Montgomery | Amerindo Investment Advisors, Inc. | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Later Stage | $8,937.50 |
| 2000 | Chester | Ben Franklin Technology Partners Southeastern PA | Orthovita, Inc. | Balanced Stage | $10,000.00 |
| 2000 | Delaware | Advanced Technology Ventures (AKA: ATV) | Afferon, Inc. | Early Stage | $0.00 |
| 2000 | Montgomery | Undisclosed Venture Firm | Protarga, Inc. | Balanced Stage | $3.00 |
| 2000 | Bucks | Individuals | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $90.00 |
| 2000 | Bucks | Undisclosed Venture Firm | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $310.90 |
| 2000 | Bucks | Aetna Life and Casualty | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $500.00 |
| 2000 | Bucks | Senmed Medical Ventures | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $500.00 |
| 2000 | Bucks | Reinvestment Fund , The (TRF) | Alpine Medical | Early Stage | $750.00 |
| 2000 | Bucks | Progress Capital Management | Alpine Medical | Early Stage | $750.00 |
| 2000 | Delaware | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Gel Med Sciences, Inc. (FKA, EIEICO, Inc.) | Early Stage | $750.00 |
| 2000 | Mercer | Johnston Associates, Inc. | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Balanced Stage | $900.00 |
| 2000 | Delaware | Safeguard Scientifics, Inc. | VueSonix Sensors | Early Stage | $975.00 |
| 2000 | Delaware | Undisclosed Investor | VueSonix Sensors | Balanced Stage | $975.00 |
| 2000 | Delaware | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | VueSonix Sensors | Early Stage | $975.00 |
| 2000 | Delaware | Mi3 Venture Partners | VueSonix Sensors | Early Stage | $975.00 |
| 2000 | Bucks | M&G Group | 3-Dimensional Pharmaceuticals, Inc. | Expansion | $1,000.00 |
| 2000 | Burlington | Mediphase Venture Partners (FKA: EHealth Technology Fund) | ImpactRx, Inc. | Balanced Stage | $1,000.00 |
| 2000 | Mercer | Venrock Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $1,157.00 |
| 2000 | Montgomery | Grosvenor Funds, The | Protarga, Inc. | Balanced Stage | $1,612.00 |
| 2000 | Bucks | Abingworth Management, Ltd. | 3-Dimensional Pharmaceuticals, Inc. | Early Stage | $1,730.00 |
| 2000 | Montgomery | equity4life AG | Protarga, Inc. | Expansion | $1,740.00 |
| 2000 | Delaware | Individuals | Gel Med Sciences, Inc. (FKA, EIEICO, Inc.) | Balanced Stage | $2,250.00 |
| 2000 | Delaware | ABS Capital Partners | Continuum Healthcare, Inc. | Later Stage | $3,000.00 |
| 2000 | Bucks | HealthCare Ventures LLC (FKA: Healthcare Investments) | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $3,067.00 |
| 2000 | Chester | CDP Capital - Technology Ventures (FKA: CDP Sofinov) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,916.70 |
| 2000 | Chester | EJ Financial | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,916.70 |
| 2000 | Chester | Vivo Ventures (FKA: BioAsia Investments LLC) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,916.70 |
| 2000 | Chester | Undisclosed Corporate Investor | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,916.70 |
| 2000 | Chester | New York Life Capital Partners (AKA: NYLCAP) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,916.70 |
| 2000 | Chester | Ontario Teachers Pension Plan | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Later Stage | $3,916.70 |
| 2000 | Bucks | HealthCare Ventures LLC (FKA: Healthcare Investments) | 3-Dimensional Pharmaceuticals, Inc. | Early Stage | $4,141.00 |
| 2000 | Delaware | CW Group, Inc. | Synergy Healthcare Services, Inc. (FKA: OBA America, Inc.) | Balanced Stage | $4,350.00 |
| 2000 | Bucks | Rho Ventures (AKA: RHO Management) | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $5,106.00 |
| 2000 | Mercer | Undisclosed Venture Firm | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Balanced Stage | $7,474.00 |
| 2000 | Mercer | New Enterprise Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $8,569.00 |
| 2000 | Bucks | Bellevue Asset Management AG | 3-Dimensional Pharmaceuticals, Inc. | Balanced Stage | $11,635.00 |
| 2001 | Chester | SightLine Partners | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Balanced Stage | $0.00 |
| 2001 | Bucks | Prince Ventures | Xylos Corporation | Early Stage | $100.00 |
| 2001 | Mercer | Medical Innovation Partners | Aesgen, Inc. | Early Stage | $200.00 |
| 2001 | Mercer | Undisclosed Venture Firm | Aesgen, Inc. | Balanced Stage | $216.70 |
| 2001 | Mercer | Individuals | Sopherion Therapeutics, Inc. | Balanced Stage | $266.70 |
| 2001 | Philadelphia | Undisclosed Venture Firm | Aphton Corporation | Balanced Stage | $375.00 |
| 2001 | Mercer | Connecticut Innovations, Inc. | Sopherion Therapeutics, Inc. | Balanced Stage | $500.00 |
| 2001 | Mercer | Undisclosed Venture Firm | Sopherion Therapeutics, Inc. | Balanced Stage | $533.40 |
| 2001 | Chester | Undisclosed Venture Firm | Nucleonics, Inc. | Balanced Stage | $600.00 |
| 2001 | Chester | Individuals | Morphotek, Inc. | Balanced Stage | $633.30 |
| 2001 | Chester | CB Health Ventures LLC | Morphotek, Inc. | Balanced Stage | $675.00 |
| 2001 | Chester | CB Health Ventures LLC | Morphotek, Inc. | Expansion | $925.00 |
| 2001 | Chester | Spray Venture Partners | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Early Stage | $998.00 |
| 2001 | Philadelphia | Societe Generale - Private Equity Activity | Aphton Corporation | Balanced Stage | $1,000.00 |
| 2001 | Philadelphia | Vertical Group, The | Aphton Corporation | Balanced Stage | $1,000.00 |
| 2001 | Montgomery | Perennial Ventures (FKA: Tredegar Investments) | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $1,000.00 |
| 2001 | Chester | S.R. One, Limited | Nucleonics, Inc. | Later Stage | $1,000.00 |
| 2001 | Mercer | Johnston Associates, Inc. | Targent, Inc. | Balanced Stage | $1,000.00 |
| 2001 | Chester | Undisclosed Investor | Morphotek, Inc. | Balanced Stage | $1,266.60 |
| 2001 | Chester | New Enterprise Associates | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Early Stage | $1,568.00 |
| 2001 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Immunicon Corporation | Balanced Stage | $2,000.00 |
| 2001 | Montgomery | equity4life AG | Immunicon Corporation | Expansion | $2,000.00 |
| 2001 | Chester | Undisclosed Venture Firm | Neuron Therapeutics, Inc. (FKA: ICTUS Pharmaceuticals) | Balanced Stage | $2,449.60 |
| 2001 | Montgomery | Delphi Ventures | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $2,880.00 |
| 2001 | Montgomery | Johnson & Johnson Development Corporation | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Later Stage | $2,880.00 |
| 2001 | Montgomery | Amerindo Investment Advisors, Inc. | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Later Stage | $2,880.00 |
| 2001 | Montgomery | Foundation Medical Partners | Immunicon Corporation | Balanced Stage | $3,000.00 |
| 2001 | Chester | Burrill & Company | Morphotek, Inc. | Early Stage | $3,000.00 |
| 2001 | Montgomery | Hillman Company | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Expansion | $3,050.00 |
| 2001 | Montgomery | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $3,050.00 |
| 2001 | Chester | Flagship Ventures | Morphotek, Inc. | Early Stage | $3,500.00 |
| 2001 | Chester | S.R. One, Limited | Message Pharmaceuticals, Inc. | Later Stage | $4,000.00 |
| 2001 | Montgomery | Canaan Partners | Immunicon Corporation | Early Stage | $4,016.00 |
| 2001 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $5,000.00 |
| 2001 | Montgomery | Burrill & Company | Immunicon Corporation | Early Stage | $5,000.00 |
| 2001 | Montgomery | Wheatley Partners | Immunicon Corporation | Balanced Stage | $6,492.00 |
| 2001 | Montgomery | Johnson & Johnson Development Corporation | Immunicon Corporation | Later Stage | $6,492.00 |
| 2001 | Mercer | TVM Capital (AKA: Techno Venture Management) (FKA: TVM) | Pharmasset, Inc. | Early Stage | $7,400.00 |
| 2001 | Montgomery | Prism Venture Partners | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Early Stage | $10,200.00 |
| 2001 | Chester | H&Q Healthcare Investors | Orthovita, Inc. | Expansion | $10,900.00 |
| 2001 | Montgomery | Undisclosed Venture Firm | Locus Pharmaceuticals, Inc. (FKA: Locus Discovery, Inc.) | Balanced Stage | $17,280.00 |
| 2001 | Delaware | Ben Franklin Technology Partners Southeastern PA | MacroArray Technologies | Balanced Stage | $250.00 |
| 2001 | Bucks | Undisclosed Investor | Heartsine Technologies | Balanced Stage | $300.00 |
| 2001 | Bucks | Crescent Capital (NI) Ltd | Heartsine Technologies | Development | $540.00 |
| 2001 | Chester | TDH II Ltd. | Animas Corporation | Later Stage | $880.00 |
| 2001 | Chester | HLM Venture Partners | Animas Corporation | Expansion | $941.00 |
| 2001 | Delaware | ABS Capital Partners | Continuum Healthcare, Inc. | Later Stage | $2,000.00 |
| 2001 | Mercer | Venrock Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $2,194.00 |
| 2001 | Burlington | Mediphase Venture Partners (FKA: EHealth Technology Fund) | ImpactRx, Inc. | Early Stage | $2,500.00 |
| 2001 | Chester | Liberty Ridge Capital (FKA: Pilgrim Baxter & Associates) | Animas Corporation | Later Stage | $3,481.00 |
| 2001 | Chester | Bank of America Sbic | Animas Corporation | Balanced Stage | $3,481.00 |
| 2001 | Chester | Johnson & Johnson Development Corporation | Animas Corporation | Later Stage | $3,481.00 |
| 2001 | Bucks | Undisclosed Investor | CollaGenex Pharmaceuticals, Inc. (FKA: Collagenex, Inc.) | Balanced Stage | $3,750.00 |
| 2001 | Bucks | Aisling Capital (FKA: Perseus-Soros Management Company) | CollaGenex Pharmaceuticals, Inc. (FKA: Collagenex, Inc.) | Later Stage | $3,750.00 |
| 2001 | Chester | HLM Venture Partners | Animas Corporation | Later Stage | $5,331.00 |
| 2001 | Burlington | Oxford Bioscience Partners | ImpactRx, Inc. | Early Stage | $5,500.00 |
| 2001 | Chester | CE Unterberg Towbin (FKA:Unterberg Harris Capital Partners) | Auxilium Pharmaceuticals, Inc. | Expansion | $5,601.20 |
| 2001 | Chester | Aisling Capital (FKA: Perseus-Soros Management Company) | Auxilium Pharmaceuticals, Inc. | Later Stage | $5,601.20 |
| 2001 | Mercer | New Enterprise Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Balanced Stage | $10,306.00 |
| 2001 | Chester | Undisclosed Venture Firm | Animas Corporation | Balanced Stage | $10,443.00 |
| 2001 | Chester | Liberty Venture Partners, Inc. | Animas Corporation | Balanced Stage | $13,481.00 |
| 2002 | Chester | Undisclosed Venture Firm | Reaction Biology Corp (FKA: Morewood Molecular Sciences Inc) | Balanced Stage | $5.00 |
| 2002 | Montgomery | SightLine Partners | Scirex Corporation | Balanced Stage | $150.00 |
| 2002 | Chester | Liberty Venture Partners, Inc. | Othera Pharmaceuticals, Inc. | Early Stage | $221.00 |
| 2002 | New Castle | Undisclosed Investor | Genome Networks, Inc. | Balanced Stage | $250.00 |
| 2002 | New Castle | Mitsui & Co. Venture Partners (MCVP) | Genome Networks, Inc. | Balanced Stage | $250.00 |
| 2002 | Chester | S.R. One, Limited | Message Pharmaceuticals, Inc. | Later Stage | $470.00 |
| 2002 | Chester | LaunchCyte LLC | Reaction Biology Corp (FKA: Morewood Molecular Sciences Inc) | Seed Stage | $500.00 |
| 2002 | Mercer | Intersouth Partners | Sopherion Therapeutics, Inc. | Early Stage | $1,498.20 |
| 2002 | Mercer | Connecticut Innovations, Inc. | Sopherion Therapeutics, Inc. | Balanced Stage | $1,498.20 |
| 2002 | Mercer | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Sopherion Therapeutics, Inc. | Early Stage | $1,498.20 |
| 2002 | Mercer | Johnson & Johnson Development Corporation | Sopherion Therapeutics, Inc. | Later Stage | $1,498.20 |
| 2002 | Chester | Alliance Technology Ventures | Neuronyx, Inc. | Seed Stage | $1,800.00 |
| 2002 | Mercer | Seaflower Ventures | Sopherion Therapeutics, Inc. | Early Stage | $2,000.00 |
| 2002 | Montgomery | Undisclosed Venture Firm | Scirex Corporation | Balanced Stage | $2,975.00 |
| 2002 | Chester | Wynnefield Capital Advisors | Othera Pharmaceuticals, Inc. | Early Stage | $3,779.00 |
| 2002 | Mercer | TL Ventures (FKA: Radnor Venture Partners) | Sopherion Therapeutics, Inc. | Early Stage | $3,998.20 |
| 2002 | Mercer | State of Wisconsin Investment Board | Cytogen Corporation | Balanced Stage | $5,000.00 |
| 2002 | Mercer | ProQuest Investments | Sopherion Therapeutics, Inc. | Balanced Stage | $5,011.00 |
| 2002 | Mercer | Undisclosed Venture Firm | Sopherion Therapeutics, Inc. | Balanced Stage | $7,500.00 |
| 2002 | Chester | Undisclosed Venture Firm | Neuronyx, Inc. | Balanced Stage | $8,200.00 |
| 2002 | Montgomery | RS Investments (AKA: Robertson Stephens & Company, LLC) | Vicuron Pharmaceuticals, Inc. (FKA: Versicor, Inc.) | Later Stage | $15,000.00 |
| 2002 | Montgomery | T. Rowe Price Threshold Partnerships | Vicuron Pharmaceuticals, Inc. (FKA: Versicor, Inc.) | Balanced Stage | $15,000.00 |
| 2002 | Bucks | Robin Hood Ventures | Power Medical Interventions | Balanced Stage | $115.00 |
| 2002 | Mercer | Capitol Health Partners, L.P. | PharmaNet | Balanced Stage | $200.00 |
| 2002 | Delaware | Milestone Venture Partners | Octagon Research Solutions, Inc. | Early Stage | $400.00 |
| 2002 | Bucks | Undisclosed Investor | Discovery Laboratories, Inc. | Balanced Stage | $1,393.00 |
| 2002 | Montgomery | Quaker BioVentures, Inc. | BioRexis Pharmaceutical Corporation | Later Stage | $1,500.00 |
| 2002 | Bucks | ACT Venture Capital, Ltd. | Heartsine Technologies | Early Stage | $2,084.00 |
| 2002 | Montgomery | Nazem & Co. | Araccel Corporation (FKA: MiniDoc I Uppsala AB) | Later Stage | $2,100.00 |
| 2002 | Burlington | Oxford Bioscience Partners | ImpactRx, Inc. | Early Stage | $3,000.00 |
| 2002 | Montgomery | Venrock Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $3,000.00 |
| 2002 | Montgomery | New Enterprise Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $3,000.00 |
| 2002 | Bucks | Vivo Ventures (FKA: BioAsia Investments LLC) | Discovery Laboratories, Inc. | Balanced Stage | $3,049.00 |
| 2002 | Montgomery | ProQuest Investments | BioRexis Pharmaceutical Corporation | Balanced Stage | $3,250.00 |
| 2002 | Montgomery | Tullis-Dickerson & Co., Inc. | BioRexis Pharmaceutical Corporation | Balanced Stage | $3,250.00 |
| 2002 | Delaware | Edison Venture Fund | Octagon Research Solutions, Inc. | Expansion | $3,400.00 |
| 2002 | Montgomery | Undisclosed Venture Firm | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Balanced Stage | $4,000.00 |
| 2002 | Chester | Aisling Capital (FKA: Perseus-Soros Management Company) | Auxilium Pharmaceuticals, Inc. | Later Stage | $4,100.00 |
| 2002 | Bucks | Undisclosed Venture Firm | Discovery Laboratories, Inc. | Balanced Stage | $4,179.00 |
| 2002 | Bucks | Undisclosed Corporate Investor | Discovery Laboratories, Inc. | Balanced Stage | $4,179.00 |
| 2002 | Mercer | TL Ventures (FKA: Radnor Venture Partners) | Barrier Therapeutics, Inc. | Early Stage | $5,000.00 |
| 2002 | Montgomery | Prospect Venture Partners (FKA: Prospect Management LLC) | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $6,000.00 |
| 2002 | Mercer | Aisling Capital (FKA: Perseus-Soros Management Company) | Barrier Therapeutics, Inc. | Later Stage | $7,000.00 |
| 2002 | Burlington | Mediphase Venture Partners (FKA: EHealth Technology Fund) | ImpactRx, Inc. | Balanced Stage | $7,000.00 |
| 2002 | Chester | Undisclosed Venture Firm | Auxilium Pharmaceuticals, Inc. | Balanced Stage | $11,325.00 |
| 2002 | Mercer | Undisclosed Venture Firm | Barrier Therapeutics, Inc. | Balanced Stage | $12,000.00 |
| 2002 | Mercer | KBC Private Equity NV | Barrier Therapeutics, Inc. | Early Stage | $12,000.00 |
| 2002 | Montgomery | equity4life AG | Protarga, Inc. | Expansion | $12,000.00 |
| 2002 | Montgomery | Deutsche Venture Capital GmbH (DVCG) | Protarga, Inc. | Early Stage | $12,000.00 |
| 2003 | Montgomery | Domain Associates LLC | Neose Technologies, Inc. | Balanced Stage | $132.00 |
| 2003 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $201.00 |
| 2003 | Montgomery | BioAdvance | RetinaPharma Technologies, Inc. | Seed Stage | $469.00 |
| 2003 | Montgomery | Undisclosed Venture Firm | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Balanced Stage | $499.00 |
| 2003 | Montgomery | Ben Franklin Technology Partners Southeastern PA | Immune Control, Inc. | Balanced Stage | $500.00 |
| 2003 | Philadelphia | BioAdvance | PhenoTech, Inc. | Seed Stage | $500.00 |
| 2003 | Chester | BioAdvance | Spliceomix | Seed Stage | $500.00 |
| 2003 | Chester | S.R. One, Limited | Message Pharmaceuticals, Inc. | Later Stage | $550.00 |
| 2003 | Chester | Burrill & Company | Morphotek, Inc. | Early Stage | $610.00 |
| 2003 | Bucks | BayTech Venture Capital Beratungs GmbH | Xylos Corporation | Early Stage | $1,011.70 |
| 2003 | Bucks | Sycamore Ventures | Xylos Corporation | Expansion | $1,011.70 |
| 2003 | Bucks | Prince Ventures | Xylos Corporation | Early Stage | $1,011.70 |
| 2003 | Montgomery | Wheatley Partners | Immunicon Corporation | Balanced Stage | $1,650.00 |
| 2003 | Montgomery | Undisclosed Corporate Investor | Immunicon Corporation | Balanced Stage | $1,730.30 |
| 2003 | Montgomery | Foundation Medical Partners | Immunicon Corporation | Balanced Stage | $1,730.30 |
| 2003 | Montgomery | Burrill & Company | Immunicon Corporation | Early Stage | $1,730.30 |
| 2003 | Montgomery | equity4life AG | Immunicon Corporation | Expansion | $1,730.30 |
| 2003 | Montgomery | MDS Health Ventures, Inc. (AKA: MDS Capital Corp.) | Immunicon Corporation | Expansion | $1,730.30 |
| 2003 | Montgomery | Johnson & Johnson Development Corporation | Immunicon Corporation | Later Stage | $1,730.30 |
| 2003 | Chester | Flagship Ventures | Morphotek, Inc. | Early Stage | $1,773.00 |
| 2003 | Chester | CB Health Ventures LLC | Morphotek, Inc. | Balanced Stage | $1,800.00 |
| 2003 | Montgomery | Anthem Capital Management | Immunicon Corporation | Early Stage | $2,000.00 |
| 2003 | Montgomery | Canaan Partners | Immunicon Corporation | Early Stage | $2,008.00 |
| 2003 | Chester | S.R. One, Limited | Morphotek, Inc. | Later Stage | $3,000.00 |
| 2003 | Montgomery | Undisclosed Investor | Immunicon Corporation | Balanced Stage | $3,460.60 |
| 2003 | Bucks | vSpring Capital | Protalex, Inc. | Early Stage | $3,500.00 |
| 2003 | Bucks | Undisclosed Investor | Protalex, Inc. | Balanced Stage | $4,250.00 |
| 2003 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Immunicon Corporation | Balanced Stage | $5,000.00 |
| 2003 | Montgomery | Domain Associates LLC | Neose Technologies, Inc. | Early Stage | $5,567.00 |
| 2003 | Chester | Forward Ventures | Morphotek, Inc. | Balanced Stage | $7,417.00 |
| 2003 | Montgomery | Undisclosed Venture Firm | Neose Technologies, Inc. | Balanced Stage | $11,501.00 |
| 2003 | Bucks | ACT Venture Capital, Ltd. | Heartsine Technologies | Early Stage | $0.00 |
| 2003 | Mercer | Capitol Health Partners, L.P. | PharmaNet | Balanced Stage | $10.00 |
| 2003 | Chester | BioAdvance | Protez Pharmaceuticals | Seed Stage | $50.00 |
| 2003 | Delaware | Ben Franklin Technology Partners Southeastern PA | TruTek, Inc. | Balanced Stage | $100.00 |
| 2003 | Chester | HLM Venture Partners | Animas Corporation | Expansion | $105.00 |
| 2003 | Bucks | Robin Hood Ventures | Power Medical Interventions | Balanced Stage | $200.00 |
| 2003 | Delaware | Mi3 Venture Partners | VueSonix Sensors | Early Stage | $200.00 |
| 2003 | Chester | BioAdvance | Eagle Vision Pharmaceutical Corporation | Seed Stage | $307.00 |
| 2003 | Philadelphia | BioAdvance | Gelifex, Inc. | Seed Stage | $405.00 |
| 2003 | Bucks | Vivo Ventures (FKA: BioAsia Investments LLC) | Discovery Laboratories, Inc. | Balanced Stage | $411.00 |
| 2003 | Delaware | BioAdvance | MacroArray Technologies | Seed Stage | $469.00 |
| 2003 | Chester | KBL Healthcare Ventures | Neuronetics, Inc. | Early Stage | $500.00 |
| 2003 | Montgomery | Johnson & Johnson Development Corporation | Replication Medical, Inc. | Later Stage | $500.00 |
| 2003 | Montgomery | Undisclosed Venture Firm | Replication Medical, Inc. | Balanced Stage | $500.00 |
| 2003 | Chester | HLM Venture Partners | Animas Corporation | Later Stage | $593.00 |
| 2003 | Mercer | Galen Associates (FKA:Galen Partners) | Derma Sciences, Inc. | Later Stage | $603.00 |
| 2003 | Chester | BTG International (AKA: British Technology Group) | Protez Pharmaceuticals | Balanced Stage | $800.00 |
| 2003 | Montgomery | Undisclosed Venture Firm | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Balanced Stage | $1,000.00 |
| 2003 | Chester | SV Life Sciences Advisers (Schroder Ventures Life Sciences) | Auxilium Pharmaceuticals, Inc. | Later Stage | $1,700.00 |
| 2003 | Mercer | Venrock Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $2,239.00 |
| 2003 | Mercer | Ventures West Management, Inc. | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Balanced Stage | $2,266.70 |
| 2003 | Mercer | GrowthWorks | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Balanced Stage | $2,266.70 |
| 2003 | Montgomery | Cardinal Partners (FKA: Cardinal Health Partners) | Replication Medical, Inc. | Early Stage | $2,500.00 |
| 2003 | Montgomery | Hillman Company | Replication Medical, Inc. | Expansion | $2,500.00 |
| 2003 | Chester | Undisclosed Venture Firm | Neuronetics, Inc. | Balanced Stage | $2,582.10 |
| 2003 | Mercer | Undisclosed Venture Firm | Barrier Therapeutics, Inc. | Balanced Stage | $2,590.40 |
| 2003 | Mercer | Johnson & Johnson Development Corporation | Barrier Therapeutics, Inc. | Later Stage | $2,590.40 |
| 2003 | Chester | InterWest Partners | Neuronetics, Inc. | Balanced Stage | $2,700.00 |
| 2003 | Chester | ONSET Ventures | Neuronetics, Inc. | Early Stage | $2,825.00 |
| 2003 | Chester | Beringea (FKA: GMA Capital LLC) (AKA: ProVen Private Equity) | Animas Corporation | Development | $3,000.00 |
| 2003 | Mercer | New Enterprise Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $3,359.00 |
| 2003 | Montgomery | New Enterprise Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $3,500.00 |
| 2003 | Montgomery | Venrock Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $3,500.00 |
| 2003 | Chester | Sprout Group | Auxilium Pharmaceuticals, Inc. | Balanced Stage | $5,918.40 |
| 2003 | Chester | Churchill Investment Partners | Auxilium Pharmaceuticals, Inc. | Later Stage | $5,918.40 |
| 2003 | Chester | Aisling Capital (FKA: Perseus-Soros Management Company) | Auxilium Pharmaceuticals, Inc. | Later Stage | $5,918.40 |
| 2003 | Chester | Bellevue Asset Management AG | Auxilium Pharmaceuticals, Inc. | Balanced Stage | $5,918.40 |
| 2003 | Mercer | Undisclosed Venture Firm | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Balanced Stage | $6,902.00 |
| 2003 | Montgomery | Prospect Venture Partners (FKA: Prospect Management LLC) | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $7,000.00 |
| 2003 | Mercer | TL Ventures (FKA: Radnor Venture Partners) | Barrier Therapeutics, Inc. | Early Stage | $8,098.00 |
| 2003 | Mercer | KBC Private Equity NV | Barrier Therapeutics, Inc. | Early Stage | $8,340.40 |
| 2003 | Mercer | Aisling Capital (FKA: Perseus-Soros Management Company) | Barrier Therapeutics, Inc. | Later Stage | $8,340.40 |
| 2003 | Philadelphia | Primus Venture Partners, Inc. | excelleRx, Inc. | Balanced Stage | $10,000.00 |
| 2003 | Philadelphia | LLR Partners, Inc. | excelleRx, Inc. | Later Stage | $15,000.00 |
| 2003 | Chester | Undisclosed Venture Firm | Animas Corporation | Balanced Stage | $16,162.00 |
| 2003 | Mercer | MPM Capital (FKA: MPM Asset Management LLC) | Barrier Therapeutics, Inc. | Balanced Stage | $16,700.00 |
| 2004 | Delaware | Innovation Philadelphia | Chaperone Technologies | Balanced Stage | $0.00 |
| 2004 | Chester | S.R. One, Limited | Message Pharmaceuticals, Inc. | Later Stage | $0.00 |
| 2004 | Chester | Liberty Venture Partners, Inc. | Othera Pharmaceuticals, Inc. | Early Stage | $342.00 |
| 2004 | Philadelphia | Undisclosed Venture Firm | Acuity Pharmaceuticals, Inc. | Balanced Stage | $500.00 |
| 2004 | Mercer | NewSpring Capital | Sopherion Therapeutics, Inc. | Balanced Stage | $500.00 |
| 2004 | Delaware | BioAdvance | Yaupon Therapeutics, Inc. | Seed Stage | $500.00 |
| 2004 | Chester | Aurora Funds, Inc. | Neotropix, Inc. | Early Stage | $625.00 |
| 2004 | Chester | VIMAC Ventures LLC (FKA: VIMAC LLC) | Neotropix, Inc. | Early Stage | $625.00 |
| 2004 | Chester | Novartis Venture Fund (FKA: Novartis Corp.) | Neotropix, Inc. | Balanced Stage | $625.00 |
| 2004 | Chester | Quaker BioVentures, Inc. | Neotropix, Inc. | Early Stage | $625.00 |
| 2004 | Mercer | Seaflower Ventures | Sopherion Therapeutics, Inc. | Early Stage | $1,000.00 |
| 2004 | Chester | Individuals | Morphotek, Inc. | Balanced Stage | $1,080.00 |
| 2004 | Chester | Undisclosed Investor | Morphotek, Inc. | Balanced Stage | $1,080.00 |
| 2004 | Chester | China Development Industrial Bank (CDIB) | Morphotek, Inc. | Balanced Stage | $1,080.00 |
| 2004 | Chester | Rock Maple Ventures, L.P. | Morphotek, Inc. | Early Stage | $1,080.00 |
| 2004 | Chester | DSM Corporate Venturing | Morphotek, Inc. | Early Stage | $1,080.00 |
| 2004 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $1,121.00 |
| 2004 | Chester | Liberty Venture Partners, Inc. | Othera Pharmaceuticals, Inc. | Expansion | $1,390.00 |
| 2004 | Philadelphia | Individuals | Acuity Pharmaceuticals, Inc. | Balanced Stage | $1,400.00 |
| 2004 | Chester | NewSpring Capital | Othera Pharmaceuticals, Inc. | Balanced Stage | $1,500.00 |
| 2004 | Chester | New Jersey Technology Council (AKA: NJTC) | Othera Pharmaceuticals, Inc. | Early Stage | $2,000.00 |
| 2004 | Mercer | MPM Capital (FKA: MPM Asset Management LLC) | Pharmasset, Inc. | Expansion | $2,000.00 |
| 2004 | Philadelphia | Diamond Capital | Acuity Pharmaceuticals, Inc. | Balanced Stage | $2,142.90 |
| 2004 | Philadelphia | BioAdvance | Acuity Pharmaceuticals, Inc. | Seed Stage | $2,142.90 |
| 2004 | Philadelphia | Johnson & Johnson Development Corporation | Acuity Pharmaceuticals, Inc. | Later Stage | $2,142.90 |
| 2004 | Philadelphia | Undisclosed Investor | Acuity Pharmaceuticals, Inc. | Balanced Stage | $2,142.90 |
| 2004 | Philadelphia | Psilos Group Managers, LLC | Acuity Pharmaceuticals, Inc. | Balanced Stage | $2,142.90 |
| 2004 | Montgomery | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $2,202.50 |
| 2004 | Montgomery | Undisclosed Venture Firm | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Balanced Stage | $2,474.00 |
| 2004 | Philadelphia | Ben Franklin Technology Partners Southeastern PA | Acuity Pharmaceuticals, Inc. | Balanced Stage | $2,642.90 |
| 2004 | Chester | Forward Ventures | Morphotek, Inc. | Balanced Stage | $3,000.00 |
| 2004 | Chester | Morgenthaler Ventures | Morphotek, Inc. | Early Stage | $3,000.00 |
| 2004 | Chester | S.R. One, Limited | Nucleonics, Inc. | Later Stage | $3,700.00 |
| 2004 | Chester | Anthem Capital Management | Nucleonics, Inc. | Early Stage | $3,767.00 |
| 2004 | Mercer | Undisclosed Venture Firm | Pharmasset, Inc. | Balanced Stage | $4,000.00 |
| 2004 | Mercer | TVM Capital (AKA: Techno Venture Management) (FKA: TVM) | Pharmasset, Inc. | Early Stage | $5,000.00 |
| 2004 | Chester | Johnson & Johnson Development Corporation | Othera Pharmaceuticals, Inc. | Later Stage | $5,008.50 |
| 2004 | Chester | NewSpring Capital | Othera Pharmaceuticals, Inc. | Expansion | $5,008.50 |
| 2004 | Mercer | Canaan Partners | Sopherion Therapeutics, Inc. | Early Stage | $6,000.00 |
| 2004 | Montgomery | Scheer & Company | Tengion, Inc. | Seed Stage | $6,283.30 |
| 2004 | Montgomery | Johnson & Johnson Development Corporation | Tengion, Inc. | Later Stage | $6,283.30 |
| 2004 | Montgomery | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Tengion, Inc. | Later Stage | $6,283.30 |
| 2004 | Mercer | Sprout Group | Sopherion Therapeutics, Inc. | Balanced Stage | $6,781.30 |
| 2004 | Mercer | NewSpring Capital | Sopherion Therapeutics, Inc. | Expansion | $6,781.30 |
| 2004 | Mercer | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Sopherion Therapeutics, Inc. | Later Stage | $6,781.30 |
| 2004 | Mercer | ProQuest Investments | Sopherion Therapeutics, Inc. | Balanced Stage | $6,781.30 |
| 2004 | Chester | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Nucleonics, Inc. | Later Stage | $7,383.30 |
| 2004 | Chester | Burrill & Company | Nucleonics, Inc. | Balanced Stage | $7,383.30 |
| 2004 | Chester | New Enterprise Associates | Nucleonics, Inc. | Early Stage | $8,183.30 |
| 2004 | Chester | POSCO BioVentures | Nucleonics, Inc. | Balanced Stage | $10,483.30 |
| 2004 | Mercer | Burrill & Company | Pharmasset, Inc. | Balanced Stage | $11,000.00 |
| 2004 | Mercer | MDS Health Ventures, Inc. (AKA: MDS Capital Corp.) | Pharmasset, Inc. | Balanced Stage | $11,000.00 |
| 2004 | Mercer | CDIB BioScience Venture Management | Pharmasset, Inc. | Expansion | $11,000.00 |
| 2004 | Mercer | TL Ventures (FKA: Radnor Venture Partners) | Sopherion Therapeutics, Inc. | Early Stage | $12,375.00 |
| 2004 | Montgomery | Oak Investment Partners | Tengion, Inc. | Balanced Stage | $15,000.00 |
| 2004 | Bucks | ACT Venture Capital, Ltd. | Heartsine Technologies | Early Stage | $0.00 |
| 2004 | Mercer | Venrock Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $0.00 |
| 2004 | Mercer | New Enterprise Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $0.00 |
| 2004 | Delaware | Safeguard Scientifics, Inc. | VueSonix Sensors | Early Stage | $0.00 |
| 2004 | Delaware | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | VueSonix Sensors | Early Stage | $0.00 |
| 2004 | Montgomery | Tullis-Dickerson & Co., Inc. | BioRexis Pharmaceutical Corporation | Balanced Stage | $6.00 |
| 2004 | Montgomery | Ben Franklin Technology Partners Southeastern PA | TheraQuest Biosciences, Inc. | Balanced Stage | $125.00 |
| 2004 | Montgomery | BioAdvance | TheraQuest Biosciences, Inc. | Balanced Stage | $125.00 |
| 2004 | Delaware | Mi3 Venture Partners | VueSonix Sensors | Early Stage | $132.00 |
| 2004 | Montgomery | Cardinal Partners (FKA: Cardinal Health Partners) | Replication Medical, Inc. | Early Stage | $276.00 |
| 2004 | Montgomery | Hillman Company | Replication Medical, Inc. | Expansion | $362.00 |
| 2004 | Delaware | Undisclosed Venture Firm | VueSonix Sensors | Balanced Stage | $368.00 |
| 2004 | Chester | Anthem Capital Management | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $500.00 |
| 2004 | Chester | New Jersey Technology Council (AKA: NJTC) | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $500.00 |
| 2004 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $500.00 |
| 2004 | Philadelphia | BioAdvance | Cira Discovery Sciences | Seed Stage | $500.00 |
| 2004 | Chester | Vivo Ventures (FKA: BioAsia Investments LLC) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $500.00 |
| 2004 | Chester | BioAdvance | Protez Pharmaceuticals | Seed Stage | $500.00 |
| 2004 | Montgomery | BioAdvance | TheraQuest Biosciences, Inc. | Seed Stage | $500.00 |
| 2004 | Montgomery | Anthem Capital Management | BioRexis Pharmaceutical Corporation | Early Stage | $1,000.00 |
| 2004 | Montgomery | NewSpring Capital | RecoverCare, LLC | Balanced Stage | $1,000.00 |
| 2004 | Mercer | Mid-Atlantic Venture Funds (FKA: NEPA Management Corp.) | CareGain Inc. | Early Stage | $1,133.30 |
| 2004 | Mercer | Milestone Venture Partners | CareGain Inc. | Early Stage | $1,133.30 |
| 2004 | Mercer | New Jersey Technology Council (AKA: NJTC) | CareGain Inc. | Early Stage | $1,133.30 |
| 2004 | Mercer | Select Capital Ventures | CareGain Inc. | Early Stage | $1,133.30 |
| 2004 | Mercer | Inflection Point Ventures | CareGain Inc. | Early Stage | $1,133.30 |
| 2004 | Mercer | Newlight Associates | CareGain Inc. | Balanced Stage | $1,133.30 |
| 2004 | Burlington | Mediphase Venture Partners (FKA: EHealth Technology Fund) | ImpactRx, Inc. | Balanced Stage | $1,766.70 |
| 2004 | Burlington | Oxford Bioscience Partners | ImpactRx, Inc. | Balanced Stage | $1,766.70 |
| 2004 | Mercer | Undisclosed Venture Firm | Onconova Therapeutics, Inc. | Balanced Stage | $1,848.80 |
| 2004 | Mercer | ICICI Venture Funds Management Co., Pvt. Ltd. (FKA: TDICI) | Onconova Therapeutics, Inc. | Balanced Stage | $1,848.80 |
| 2004 | Mercer | Individuals | Onconova Therapeutics, Inc. | Balanced Stage | $1,848.80 |
| 2004 | Montgomery | New Enterprise Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $2,512.50 |
| 2004 | Chester | Ontario Teachers Pension Plan | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Later Stage | $3,350.00 |
| 2004 | Chester | CDP Capital - Technology Ventures (FKA: CDP Sofinov) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | Cross Atlantic Capital Partners | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | Birchmere Ventures | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Early Stage | $3,350.00 |
| 2004 | Chester | Pacific Rim Ventures | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | New York Life Capital Partners (AKA: NYLCAP) | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | Easton Hunt Capital Partners, L.P. | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | Emerging Technology Partners, LLC | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Chester | EJ Financial | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Balanced Stage | $3,350.00 |
| 2004 | Montgomery | Intel Capital | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Balanced Stage | $3,512.50 |
| 2004 | Montgomery | Johnson & Johnson Development Corporation | BioRexis Pharmaceutical Corporation | Later Stage | $3,745.00 |
| 2004 | Montgomery | Undisclosed Investor | BioRexis Pharmaceutical Corporation | Balanced Stage | $3,745.00 |
| 2004 | Chester | HealthCare Ventures LLC (FKA: Healthcare Investments) | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Balanced Stage | $4,000.00 |
| 2004 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Early Stage | $4,000.00 |
| 2004 | Chester | Cross Atlantic Partners, Inc. | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Later Stage | $5,000.00 |
| 2004 | Bucks | Mellon Ventures, Inc. | Physicians Endoscopy, LLC | Balanced Stage | $5,000.00 |
| 2004 | Montgomery | Essex Woodlands Health Ventures (FKA: Woodlands Venture) | Prism Pharmaceuticals, Inc. | Balanced Stage | $5,000.00 |
| 2004 | Montgomery | Quaker BioVentures, Inc. | BioRexis Pharmaceutical Corporation | Later Stage | $6,450.00 |
| 2004 | Chester | Quaker BioVentures, Inc. | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Later Stage | $7,000.00 |
| 2004 | Philadelphia | Burrill & Company | Cardiokine, Inc. | Balanced Stage | $7,400.00 |
| 2004 | Philadelphia | Care Capital, LLC | Cardiokine, Inc. | Later Stage | $7,400.00 |
| 2004 | Philadelphia | Aisling Capital (FKA: Perseus-Soros Management Company) | Cardiokine, Inc. | Later Stage | $7,400.00 |
| 2004 | Philadelphia | HealthCare Ventures LLC (FKA: Healthcare Investments) | Cardiokine, Inc. | Balanced Stage | $7,400.00 |
| 2004 | Montgomery | Prism Venture Partners | BioRexis Pharmaceutical Corporation | Early Stage | $7,500.00 |
| 2004 | Montgomery | ProQuest Investments | BioRexis Pharmaceutical Corporation | Balanced Stage | $7,554.00 |
| 2004 | Burlington | 3i Group PLC | ImpactRx, Inc. | Balanced Stage | $9,000.00 |
| 2004 | Montgomery | Venrock Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $9,825.00 |
| 2004 | Montgomery | Atlas Venture, Ltd. | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $10,400.00 |
| 2004 | Chester | New Enterprise Associates | EXIMIAS Pharmaceutical Corp. (FKA: Zarix, Inc.) | Early Stage | $15,000.00 |
| 2004 | Montgomery | Prospect Venture Partners (FKA: Prospect Management LLC) | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $17,750.00 |
| 2005 | New Castle | Summit Partners | B&W TEK, Inc. | Balanced Stage | $0.00 |
| 2005 | Chester | Quaker BioVentures, Inc. | Neotropix, Inc. | Early Stage | $182.00 |
| 2005 | Chester | Anthem Capital Management | Nucleonics, Inc. | Early Stage | $263.00 |
| 2005 | Chester | S.R. One, Limited | Nucleonics, Inc. | Later Stage | $367.00 |
| 2005 | Chester | BioAdvance | Melior Discovery, Inc. | Seed Stage | $500.00 |
| 2005 | Chester | CB Health Ventures LLC | Morphotek, Inc. | Balanced Stage | $540.00 |
| 2005 | Chester | Quaker BioVentures, Inc. | Nucleonics, Inc. | Later Stage | $650.00 |
| 2005 | Chester | Burrill & Company | Nucleonics, Inc. | Balanced Stage | $985.00 |
| 2005 | Chester | Novartis Venture Fund (FKA: Novartis Corp.) | Neotropix, Inc. | Balanced Stage | $988.00 |
| 2005 | Chester | Aurora Funds, Inc. | Neotropix, Inc. | Early Stage | $988.00 |
| 2005 | Montgomery | Domain Associates LLC | Immune Control, Inc. | Early Stage | $1,202.00 |
| 2005 | Montgomery | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Tengion, Inc. | Later Stage | $1,312.50 |
| 2005 | Montgomery | Oak Investment Partners | Tengion, Inc. | Balanced Stage | $1,312.50 |
| 2005 | Montgomery | Johnson & Johnson Development Corporation | Tengion, Inc. | Later Stage | $1,312.50 |
| 2005 | Montgomery | Scheer & Company | Tengion, Inc. | Seed Stage | $1,312.50 |
| 2005 | Chester | Flagship Ventures | Morphotek, Inc. | Early Stage | $1,400.00 |
| 2005 | Chester | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Nucleonics, Inc. | Later Stage | $1,450.00 |
| 2005 | Chester | Quaker BioVentures, Inc. | Neotropix, Inc. | Later Stage | $1,642.00 |
| 2005 | Montgomery | Undisclosed Venture Firm | Immune Control, Inc. | Balanced Stage | $1,749.00 |
| 2005 | Montgomery | Anthem Capital Management | Immune Control, Inc. | Early Stage | $1,925.00 |
| 2005 | Montgomery | NewSpring Capital | Immune Control, Inc. | Expansion | $1,950.00 |
| 2005 | Mercer | ProQuest Investments | Cytogen Corporation | Balanced Stage | $1,963.00 |
| 2005 | Montgomery | Quaker BioVentures, Inc. | Immune Control, Inc. | Early Stage | $2,000.00 |
| 2005 | Montgomery | Anthem Capital Management | Immunicon Corporation | Early Stage | $2,000.00 |
| 2005 | Chester | Morgenthaler Ventures | Morphotek, Inc. | Early Stage | $2,000.00 |
| 2005 | Chester | S.R. One, Limited | Morphotek, Inc. | Later Stage | $2,000.00 |
| 2005 | Chester | Forward Ventures | Morphotek, Inc. | Balanced Stage | $2,000.00 |
| 2005 | Bucks | vSpring Capital | Protalex, Inc. | Early Stage | $2,100.00 |
| 2005 | Chester | New Enterprise Associates | Nucleonics, Inc. | Early Stage | $2,285.00 |
| 2005 | Chester | Undisclosed Venture Firm | Morphotek, Inc. | Balanced Stage | $2,360.00 |
| 2005 | Montgomery | Domain Associates LLC | Immune Control, Inc. | Balanced Stage | $2,474.00 |
| 2005 | Bucks | Undisclosed Venture Firm | Protalex, Inc. | Balanced Stage | $3,000.00 |
| 2005 | Mercer | Undisclosed Venture Firm | Cytogen Corporation | Balanced Stage | $12,037.00 |
| 2005 | Montgomery | Undisclosed Venture Firm | Immunicon Corporation | Balanced Stage | $17,700.00 |
| 2005 | Bucks | ACT Venture Capital, Ltd. | Heartsine Technologies | Early Stage | $0.00 |
| 2005 | Philadelphia | Undisclosed Venture Firm | iCeutica, Inc. | Balanced Stage | $0.00 |
| 2005 | Mercer | Ampersand Ventures | RadPharm, Inc. | Balanced Stage | $0.00 |
| 2005 | Bucks | Undisclosed Investor | SP Industries, Inc. | Balanced Stage | $0.00 |
| 2005 | Mercer | Undisclosed Venture Firm | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Balanced Stage | $4.00 |
| 2005 | Mercer | Domain Associates LLC | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Early Stage | $106.00 |
| 2005 | Montgomery | Undisclosed Investor | Prism Pharmaceuticals, Inc. | Balanced Stage | $200.00 |
| 2005 | Montgomery | Essex Woodlands Health Ventures (FKA: Woodlands Venture) | Prism Pharmaceuticals, Inc. | Balanced Stage | $200.00 |
| 2005 | Montgomery | Cardinal Partners (FKA: Cardinal Health Partners) | Replication Medical, Inc. | Early Stage | $276.00 |
| 2005 | Chester | Undisclosed Venture Firm | Protez Pharmaceuticals | Balanced Stage | $370.00 |
| 2005 | Chester | Robin Hood Ventures | Protez Pharmaceuticals | Balanced Stage | $430.00 |
| 2005 | Philadelphia | BioAdvance | InfraScan, Inc. | Seed Stage | $450.00 |
| 2005 | Philadelphia | BioAdvance | Avid Radiopharmaceuticals, Inc. | Seed Stage | $500.00 |
| 2005 | Philadelphia | BioAdvance | Galleon Pharmaceuticals, Inc. | Seed Stage | $500.00 |
| 2005 | Philadelphia | BioAdvance | Jenrin Discovery, LLC | Seed Stage | $500.00 |
| 2005 | Chester | BioAdvance | Marillion Pharmaceuticals, Inc. | Seed Stage | $500.00 |
| 2005 | Montgomery | BioAdvance | NuPathe, Inc. | Seed Stage | $500.00 |
| 2005 | Montgomery | Individuals | NuPathe, Inc. | Balanced Stage | $500.00 |
| 2005 | Montgomery | BioAdvance | SansRosa Pharmaceutical Development, Inc. | Seed Stage | $500.00 |
| 2005 | Montgomery | Atlas Venture, Ltd. | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $700.00 |
| 2005 | Montgomery | Undisclosed Venture Firm | Replication Medical, Inc. | Balanced Stage | $724.00 |
| 2005 | Chester | S.R. One, Limited | Protez Pharmaceuticals | Later Stage | $779.00 |
| 2005 | Mercer | Quaker BioVentures, Inc. | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Early Stage | $800.00 |
| 2005 | Chester | New Jersey Technology Council (AKA: NJTC) | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $823.00 |
| 2005 | Mercer | Undisclosed Venture Firm | Onconova Therapeutics, Inc. | Balanced Stage | $855.90 |
| 2005 | Mercer | Venrock Associates | Vela Pharmaceuticals, Inc. (FKA: Janus Pharmaceuticals) | Early Stage | $947.00 |
| 2005 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $1,047.00 |
| 2005 | Chester | Anthem Capital Management | CerionX, Inc. (FKA: Microplate Automation, Inc.) | Early Stage | $1,380.00 |
| 2005 | Delaware | Edison Venture Fund | Octagon Research Solutions, Inc. | Expansion | $1,750.00 |
| 2005 | Delaware | Milestone Venture Partners | Octagon Research Solutions, Inc. | Early Stage | $1,750.00 |
| 2005 | Chester | Accuitive Medical Ventures LLC (AKA: AMV Partners) | Neuronetics, Inc. | Early Stage | $1,851.00 |
| 2005 | Chester | Merlin BioMed Group | Auxilium Pharmaceuticals, Inc. | Later Stage | $2,000.00 |
| 2005 | Chester | ONSET Ventures | Neuronetics, Inc. | Early Stage | $2,044.00 |
| 2005 | Philadelphia | Lilly Ventures (FKA: e.Lilly Ventures) | Avid Radiopharmaceuticals, Inc. | Early Stage | $2,133.30 |
| 2005 | Philadelphia | BioAdvance | Avid Radiopharmaceuticals, Inc. | Balanced Stage | $2,133.30 |
| 2005 | Philadelphia | Undisclosed Venture Firm | Avid Radiopharmaceuticals, Inc. | Balanced Stage | $2,133.30 |
| 2005 | Bucks | Undisclosed Venture Firm | Heartsine Technologies | Balanced Stage | $2,147.00 |
| 2005 | Mercer | Individuals | Onconova Therapeutics, Inc. | Balanced Stage | $2,167.20 |
| 2005 | Mercer | Undisclosed Corporate Investor | Onconova Therapeutics, Inc. | Balanced Stage | $2,167.20 |
| 2005 | Mercer | ICICI Venture Funds Management Co., Pvt. Ltd. (FKA: TDICI) | Onconova Therapeutics, Inc. | Balanced Stage | $2,167.20 |
| 2005 | Chester | InterWest Partners | Neuronetics, Inc. | Balanced Stage | $2,184.20 |
| 2005 | Mercer | Undisclosed Venture Firm | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Balanced Stage | $2,333.30 |
| 2005 | Philadelphia | Pfizer Strategic Investments Group (PSIG) | Avid Radiopharmaceuticals, Inc. | Balanced Stage | $2,500.00 |
| 2005 | Chester | Quaker BioVentures, Inc. | Protez Pharmaceuticals | Early Stage | $2,500.00 |
| 2005 | Chester | L Capital Partners | Protez Pharmaceuticals | Expansion | $2,505.20 |
| 2005 | Chester | BTG International (AKA: British Technology Group) | Protez Pharmaceuticals | Early Stage | $2,505.20 |
| 2005 | Chester | Undisclosed Investor | Protez Pharmaceuticals | Balanced Stage | $2,505.20 |
| 2005 | Philadelphia | Aisling Capital (FKA: Perseus-Soros Management Company) | Cardiokine, Inc. | Later Stage | $2,528.80 |
| 2005 | Philadelphia | Burrill & Company | Cardiokine, Inc. | Balanced Stage | $2,528.80 |
| 2005 | Philadelphia | Care Capital, LLC | Cardiokine, Inc. | Balanced Stage | $2,528.80 |
| 2005 | Mercer | Adams Street Partners LLC (FKA: Brinson Private Equity) | RadPharm, Inc. | Expansion | $3,500.00 |
| 2005 | Bucks | Hercules Technology Growth Capital, Inc. | Power Medical Interventions | Balanced Stage | $4,000.00 |
| 2005 | Montgomery | Undisclosed Corporate Investor | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Balanced Stage | $4,006.00 |
| 2005 | Mercer | Undisclosed Investor | Onconova Therapeutics, Inc. | Balanced Stage | $4,334.40 |
| 2005 | Chester | Three Arch Partners | Neuronetics, Inc. | Later Stage | $4,368.40 |
| 2005 | Chester | Three Arch Partners | Neuronetics, Inc. | Early Stage | $4,368.40 |
| 2005 | Chester | Birchmere Ventures | Protez Pharmaceuticals | Early Stage | $5,010.40 |
| 2005 | Philadelphia | HealthCare Ventures LLC (FKA: Healthcare Investments) | Cardiokine, Inc. | Balanced Stage | $5,785.00 |
| 2005 | Mercer | Ventures West Management, Inc. | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Early Stage | $6,000.00 |
| 2005 | Mercer | Quaker BioVentures, Inc. | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Later Stage | $6,866.70 |
| 2005 | Chester | Undisclosed Venture Firm | Auxilium Pharmaceuticals, Inc. | Balanced Stage | $8,000.00 |
| 2005 | Mercer | TL Ventures (FKA: Radnor Venture Partners) | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Early Stage | $8,000.00 |
| 2005 | Montgomery | Venrock Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $8,609.50 |
| 2005 | Montgomery | New Enterprise Associates | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $8,757.50 |
| 2005 | Mercer | Domain Associates LLC | Celator Pharmaceuticals, Inc. (FKA: Celator Technologies) | Balanced Stage | $9,894.00 |
| 2005 | Montgomery | Abbott Laboratories | Replication Medical, Inc. | Balanced Stage | $15,000.00 |
| 2005 | Mercer | Undisclosed Venture Firm | RadPharm, Inc. | Balanced Stage | $17,500.00 |
| 2005 | Montgomery | Prospect Venture Partners (FKA: Prospect Management LLC) | Vitae Pharmaceuticals, Inc. (FKA:Concurrent Pharmaceuticals) | Early Stage | $19,091.00 |
| 2006 | Chester | Undisclosed Corporate Investor | Medior, Inc. (FKA: Crovela Biophram, Inc.) | Balanced Stage | $0.00 |
| 2006 | Montgomery | Domain Associates LLC | Immune Control, Inc. | Early Stage | $13.30 |
| 2006 | Montgomery | NewSpring Capital | Immune Control, Inc. | Balanced Stage | $200.00 |
| 2006 | Chester | Liberty Venture Partners, Inc. | Othera Pharmaceuticals, Inc. | Expansion | $400.00 |
| 2006 | Montgomery | NewSpring Capital | Immune Control, Inc. | Expansion | $488.00 |
| 2006 | Delaware | BioAdvance | Yaupon Therapeutics, Inc. | Seed Stage | $500.00 |
| 2006 | Montgomery | Undisclosed Venture Firm | Immune Control, Inc. | Balanced Stage | $887.00 |
| 2006 | Chester | Easton Hunt Capital Partners, L.P. | Medior, Inc. (FKA: Crovela Biophram, Inc.) | Balanced Stage | $1,000.00 |
| 2006 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Neuronyx, Inc. | Early Stage | $1,011.00 |
| 2006 | Chester | Undisclosed Investor | Neuronyx, Inc. | Balanced Stage | $1,011.00 |
| 2006 | Delaware | Ben Franklin Technology Partners Southeastern PA | Yaupon Therapeutics, Inc. | Balanced Stage | $1,166.70 |
| 2006 | Delaware | Osage Investments | Yaupon Therapeutics, Inc. | Early Stage | $1,166.70 |
| 2006 | Delaware | TDH II Ltd. | Yaupon Therapeutics, Inc. | Later Stage | $1,166.70 |
| 2006 | Montgomery | Domain Associates LLC | Immune Control, Inc. | Balanced Stage | $1,236.70 |
| 2006 | Chester | Undisclosed Investor | Neotropix, Inc. | Balanced Stage | $1,266.70 |
| 2006 | Chester | Quaker BioVentures, Inc. | Neotropix, Inc. | Later Stage | $1,266.70 |
| 2006 | Chester | New Jersey Technology Council (AKA: NJTC) | Othera Pharmaceuticals, Inc. | Early Stage | $1,500.00 |
| 2006 | Montgomery | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $1,908.50 |
| 2006 | Chester | HealthCare Ventures LLC (FKA: Healthcare Investments) | Medior, Inc. (FKA: Crovela Biophram, Inc.) | Balanced Stage | $2,000.00 |
| 2006 | Chester | Polaris Venture Partners | Medior, Inc. (FKA: Crovela Biophram, Inc.) | Balanced Stage | $2,000.00 |
| 2006 | Chester | Morgenthaler Ventures | Medior, Inc. (FKA: Crovela Biophram, Inc.) | Balanced Stage | $2,000.00 |
| 2006 | Montgomery | TL Ventures (FKA: Radnor Venture Partners) | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Early Stage | $2,183.00 |
| 2006 | Montgomery | L Capital Partners | Tengion, Inc. | Expansion | $2,208.00 |
| 2006 | Chester | Aurora Funds, Inc. | Neotropix, Inc. | Early Stage | $2,212.70 |
| 2006 | Chester | Alliance Technology Ventures | Neuronyx, Inc. | Seed Stage | $2,729.00 |
| 2006 | Chester | Flagship Ventures | Morphotek, Inc. | Early Stage | $3,234.00 |
| 2006 | Chester | Osage Investments | Melior Discovery, Inc. | Early Stage | $3,700.00 |
| 2006 | Chester | Undisclosed Venture Firm | Neuronyx, Inc. | Balanced Stage | $3,799.00 |
| 2006 | Chester | Morgenthaler Ventures | Morphotek, Inc. | Early Stage | $3,838.00 |
| 2006 | Chester | S.R. One, Limited | Morphotek, Inc. | Later Stage | $3,838.00 |
| 2006 | Chester | MDS Health Ventures, Inc. (AKA: MDS Capital Corp.) | Morphotek, Inc. | Balanced Stage | $4,155.70 |
| 2006 | Chester | Hunt BioVentures | Morphotek, Inc. | Early Stage | $4,155.70 |
| 2006 | Chester | Burrill & Company | Morphotek, Inc. | Early Stage | $4,155.70 |
| 2006 | Chester | Forward Ventures | Morphotek, Inc. | Balanced Stage | $4,155.70 |
| 2006 | Chester | Rock Maple Ventures, L.P. | Morphotek, Inc. | Balanced Stage | $4,155.70 |
| 2006 | Chester | CB Health Ventures LLC | Morphotek, Inc. | Balanced Stage | $4,155.70 |
| 2006 | Chester | Wynnefield Capital Advisors | Othera Pharmaceuticals, Inc. | Early Stage | $4,963.30 |
| 2006 | Chester | NewSpring Capital | Othera Pharmaceuticals, Inc. | Balanced Stage | $4,963.30 |
| 2006 | Chester | Undisclosed Corporate Investor | Othera Pharmaceuticals, Inc. | Balanced Stage | $4,963.30 |
| 2006 | Chester | Johnson & Johnson Development Corporation | Othera Pharmaceuticals, Inc. | Later Stage | $4,963.30 |
| 2006 | Montgomery | Undisclosed Investor | Tengion, Inc. | Balanced Stage | $5,194.70 |
| 2006 | Montgomery | Bain Capital | Tengion, Inc. | Early Stage | $5,194.70 |
| 2006 | Montgomery | BioAdvance | Tengion, Inc. | Balanced Stage | $5,194.70 |
| 2006 | Montgomery | Johnson & Johnson Development Corporation | Tengion, Inc. | Later Stage | $5,194.70 |
| 2006 | Montgomery | Odlander, Fredrikson & Co. AB (AKA: HealthCap) | Tengion, Inc. | Later Stage | $5,194.70 |
| 2006 | Montgomery | ProQuest Investments | Agile Therapeutics, Inc. (FKA: Levotech Inc.) | Balanced Stage | $6,000.00 |
| 2006 | Montgomery | Atlas Venture, Ltd. | InfaCare Pharmaceutical Corporation | Balanced Stage | $6,000.00 |
| 2006 | Montgomery | Pequot Capital Management, Inc. | InfaCare Pharmaceutical Corporation | Expansion | $6,000.00 |
| 2006 | Montgomery | Oak Investment Partners | Tengion, Inc. | Balanced Stage | $6,624.00 |
| 2006 | Montgomery | Quaker BioVentures, Inc. | Tengion, Inc. | Balanced Stage | $10,000.00 |
| 2006 | Montgomery | Robin Hood Ventures | Bioconnect Systems, Inc. | Balanced Stage | $0.00 |
| 2006 | Montgomery | Undisclosed Venture Firm | Bioconnect Systems, Inc. | Balanced Stage | $0.00 |
| 2006 | Montgomery | Individuals | Bioconnect Systems, Inc. | Balanced Stage | $0.00 |
| 2006 | Bucks | Undisclosed Venture Firm | Heartsine Technologies | Balanced Stage | $0.00 |
| 2006 | Bucks | Enterprise Equity Venture Capital Group | Heartsine Technologies | Early Stage | $0.00 |
| 2006 | Philadelphia | Ben Franklin Technology Partners Southeastern PA | MicroMRI, Inc. | Balanced Stage | $0.00 |
| 2006 | Chester | Domain Associates LLC | Acureon Pharmaceuticals, Inc. | Early Stage | $9.00 |
| 2006 | Montgomery | Individuals | Midway Pharmaceuticals, Inc. | Balanced Stage | $70.00 |
| 2006 | Camden | Undisclosed Venture Firm | Andrew Technologies, Inc. | Balanced Stage | $110.00 |
| 2006 | Philadelphia | Ben Franklin Technology Partners Southeastern PA | Neuro Diagnostic Devices | Balanced Stage | $250.00 |
| 2006 | Camden | New Jersey Technology Council (AKA: NJTC) | Andrew Technologies, Inc. | Early Stage | $300.00 |
| 2006 | Montgomery | BioAdvance | Midway Pharmaceuticals, Inc. | Seed Stage | $500.00 |
| 2006 | Mercer | Individuals | Onconova Therapeutics, Inc. | Balanced Stage | $519.80 |
| 2006 | Montgomery | Undisclosed Venture Firm | Pharmena North America, Inc. | Balanced Stage | $588.00 |
| 2006 | Montgomery | Quaker BioVentures, Inc. | Theranox, Inc. | Early Stage | $680.00 |
| 2006 | Chester | Birchmere Ventures | Protez Pharmaceuticals | Early Stage | $680.40 |
| 2006 | Delaware | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | Gel Med Sciences, Inc. (FKA, EIEICO, Inc.) | Early Stage | $700.00 |
| 2006 | Chester | L Capital Partners | Protez Pharmaceuticals | Expansion | $750.90 |
| 2006 | Chester | Undisclosed Investor | Protez Pharmaceuticals | Balanced Stage | $750.90 |
| 2006 | Chester | BTG International (AKA: British Technology Group) | Protez Pharmaceuticals | Early Stage | $750.90 |
| 2006 | Chester | S.R. One, Limited | Protez Pharmaceuticals | Later Stage | $750.90 |
| 2006 | Chester | Quaker BioVentures, Inc. | Protez Pharmaceuticals | Early Stage | $760.00 |
| 2006 | Chester | Domain Associates LLC | Acureon Pharmaceuticals, Inc. | Balanced Stage | $792.00 |
| 2006 | Montgomery | Axcel Industriinvestor AS | RecoverCare, LLC | Expansion | $842.50 |
| 2006 | Montgomery | Undisclosed Venture Firm | RecoverCare, LLC | Balanced Stage | $842.50 |
| 2006 | Chester | Alta Partners | Acureon Pharmaceuticals, Inc. | Balanced Stage | $849.00 |
| 2006 | Chester | New Enterprise Associates | Acureon Pharmaceuticals, Inc. | Balanced Stage | $850.00 |
| 2006 | Montgomery | NewSpring Capital | Theranox, Inc. | Balanced Stage | $1,104.00 |
| 2006 | Chester | Easton Hunt Capital Partners, L.P. | Protez Pharmaceuticals | Balanced Stage | $1,556.00 |
| 2006 | Montgomery | NewSpring Capital | Theranox, Inc. | Expansion | $1,558.00 |
| 2006 | Mercer | Undisclosed Investor | Onconova Therapeutics, Inc. | Balanced Stage | $1,559.40 |
| 2006 | Montgomery | Birchmere Ventures | NuPathe, Inc. | Early Stage | $2,000.00 |
| 2006 | Montgomery | Quaker BioVentures, Inc. | NuPathe, Inc. | Early Stage | $2,000.00 |
| 2006 | Delaware | Ticonderoga Capital, Inc. (FKA: Dillon Read Venture Capital) | Octagon Research Solutions, Inc. | Early Stage | $2,000.00 |
| 2006 | Delaware | Edison Venture Fund | Octagon Research Solutions, Inc. | Expansion | $2,000.00 |
| 2006 | Chester | Amgen, Inc. | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Early Stage | $2,000.00 |
| 2006 | Chester | Individuals | Neuronetics, Inc. | Balanced Stage | $2,777.80 |
| 2006 | Chester | InterWest Partners | Neuronetics, Inc. | Balanced Stage | $2,777.80 |
| 2006 | Chester | ONSET Ventures | Neuronetics, Inc. | Early Stage | $2,777.80 |
| 2006 | Chester | KBL Healthcare Ventures | Neuronetics, Inc. | Early Stage | $2,777.80 |
| 2006 | Chester | PA Early Stage (AKA: Pennsylvania Early Stage Partners) | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Early Stage | $3,200.00 |
| 2006 | Chester | HealthCare Ventures LLC (FKA: Healthcare Investments) | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Balanced Stage | $3,354.00 |
| 2006 | Bucks | Undisclosed Investor | Quinnova Pharmaceuticals, Inc. | Balanced Stage | $3,800.00 |
| 2006 | Montgomery | Domain Associates LLC | Pharmena North America, Inc. | Early Stage | $4,000.00 |
| 2006 | Bucks | Spencer Trask Ventures, Inc. (FKA: Spencer Trask Securities) | Prescient Medical, Inc. | Balanced Stage | $4,448.00 |
| 2006 | Montgomery | Undisclosed Corporate Investor | Theranox, Inc. | Balanced Stage | $4,588.00 |
| 2006 | Chester | Vertical Group, The | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Balanced Stage | $5,100.00 |
| 2006 | Chester | Three Arch Partners | Neuronetics, Inc. | Later Stage | $5,555.60 |
| 2006 | Chester | Three Arch Partners | Neuronetics, Inc. | Early Stage | $5,555.60 |
| 2006 | Philadelphia | Advent Venture Partners LLP | Cardiokine, Inc. | Balanced Stage | $5,833.30 |
| 2006 | Philadelphia | Burrill & Company | Cardiokine, Inc. | Balanced Stage | $5,833.30 |
| 2006 | Philadelphia | Care Capital, LLC | Cardiokine, Inc. | Balanced Stage | $5,833.30 |
| 2006 | Philadelphia | Fidelity Biosciences (FKA: Fidelity Biosciences Group) | Cardiokine, Inc. | Balanced Stage | $5,833.30 |
| 2006 | Philadelphia | Ontario Teachers Pension Plan | Cardiokine, Inc. | Balanced Stage | $5,833.30 |
| 2006 | Delaware | Undisclosed Investor | Octagon Research Solutions, Inc. | Balanced Stage | $6,000.00 |
| 2006 | Bucks | Thomas, McNerney & Partners LLC | Quinnova Pharmaceuticals, Inc. | Balanced Stage | $6,000.00 |
| 2006 | Montgomery | Quaker BioVentures, Inc. | Theranox, Inc. | Later Stage | $6,070.00 |
| 2006 | Chester | Undisclosed Venture Firm | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Balanced Stage | $6,346.00 |
| 2006 | Chester | Latterell Venture Partners | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Early Stage | $7,000.00 |
| 2006 | Philadelphia | HealthCare Ventures LLC (FKA: Healthcare Investments) | Cardiokine, Inc. | Balanced Stage | $7,500.00 |
| 2006 | Philadelphia | Aisling Capital (FKA: Perseus-Soros Management Company) | Cardiokine, Inc. | Later Stage | $7,500.00 |
| 2006 | Montgomery | Essex Woodlands Health Ventures (FKA: Woodlands Venture) | Prism Pharmaceuticals, Inc. | Balanced Stage | $7,500.00 |
| 2006 | Chester | Quaker BioVentures, Inc. | TetraLogic Pharmaceuticals, Inc. (FKA: Gentara Corporation) | Balanced Stage | $9,000.00 |
| 2006 | Chester | Quaker BioVentures, Inc. | Neuronetics, Inc. | Balanced Stage | $10,000.00 |
| 2006 | Montgomery | Paul Capital Partners | Prism Pharmaceuticals, Inc. | Balanced Stage | $11,250.00 |
| 2006 | Montgomery | Undisclosed Investor | Prism Pharmaceuticals, Inc. | Balanced Stage | $11,250.00 |
| 2006 | Montgomery | Essex Woodlands Health Ventures (FKA: Woodlands Venture) | EUSA Pharma, Inc. | Balanced Stage | $20,000.00 |